Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sarcoma, Synovial × Rosuvastatin Calcium × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

TP53 Y220C Mutation 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Prostatic Neoplasms 1 Leiomyosarcoma 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Cardiovascular Diseases 1

Interventions

Cyclophosphamide 3 fludarabine 2 pasireotide 1 fludarabine phosphate 1 anlotinib 1 aldesleukin 1 Zoledronic Acid 1 Tablets 1 Rosuvastatin Calcium 1 Quality of Life 1 Midazolam 1 Interleukin-2 1 Immunotherapy, Adoptive 1 Immune Checkpoint Inhibitors 1 Digoxin 1 Dacarbazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03016819 2026-02-25

APROMISS

Advenchen Laboratories, LLC

Phase 3 Recruiting

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon ⚡